Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459

Anushka V. Goonawardena, Andrea Plano, Lianne Robinson, Ruth Ross, Iain Greig, Roger G. Pertwee, Robert E. Hampson, Bettina Platt, Gernot Riedel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


The brain endocannabinoid system is a potential target for the treatment of psychiatric and metabolic conditions. Here, a novel CB1 receptor antagonist (ABD459) was synthesized and assayed for pharmacological efficacy in vitro and for modulation of food consumption, vigilance staging and cortical electroencephalography in the mouse. ABD459 completely displaced the CB1 agonist CP99540 at a K-i of 8.6 nmol/l, and did not affect basal, but antagonized CP55940-induced GTP gamma S binding with a K-B of 7.7 nmol/l. Acute ABD459 (3-20 mg/kg) reliably inhibited food consumption in nonfasted mice, without affecting motor activity. Active food seeking was reduced for 5-6 h postdrug, with no rebound after washout. Epidural recording of electroencephalogram confirmed that ABD459 (3 mg/kg) robustly reduced rapid eye movement (REM) sleep, with no alterations of wakefulness or non-REM sleep. Effects were strongest during 3 h postdrug, followed by a progressive washout period. The CB1 antagonist AM251 (3 mg/kg) and agonist WIN-55,212-2 (WIN-2:3 mg/kg) also reduced REM, but variously affected other vigilance stages. WIN-2 caused a global suppression of normalized spectral power. AM251 and ABD459 lowered delta power and increased power in the theta band in the hippocampus, but not the prefrontal cortex. The neutral antagonist ABD459 thus showed a specific role of endocannabinoid release in attention and arousal, possibly through modulation of cholinergic activity. Behavioural Pharmacology 26:289-303 Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.

Original languageEnglish
Pages (from-to)289-303
Number of pages15
JournalBehavioural Pharmacology
Issue number3
Publication statusPublished - Apr 2015


  • agonist WIN-2
  • antagonist AM251
  • cannabinoids
  • cannabinoid receptor 1 receptors
  • electroencephalogram
  • endocannabinoid
  • mouse
  • neutral antagonist ABD459
  • nonrapid eye movement sleep
  • rapid eye movement sleep
  • receptor inverse agonist
  • short-term-memory
  • cannabinoid receptor
  • body-weight
  • in-vivo
  • hippocampal function
  • reinforced behavior
  • brain responses
  • power spectra
  • rat-brain


Dive into the research topics of 'Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459'. Together they form a unique fingerprint.

Cite this